Cardiac Insight, Inc. Email Format
Medical Equipment ManufacturingWashington, United States11-50 Employees
Cardiac Insight, Inc. is a privately held medical device company focused on cardiac diagnostics, based in the Seattle area in Washington. It has FDA clearance since 2017 for its Cardea SOLO ECG system, a wearable seven-day monitor used for comprehensive cardiac evaluations. The Cardea 20/20 ECG, created by co-founders Dr. Dave Hadley and Dr. Vic Frolicher, complements its lineup as a handheld 12-lead device intended to improve reliability in detecting cardiovascular issues in young athletes. The firm sits in the medical equipment manufacturing space, combining wearable sensing with automated analysis to support cardiology care. Its customers include clinicians and telehealth-enabled cardiology practices seeking remote monitoring and athletic heart screening capabilities, addressing the need for timely identification of complex cardiac abnormalities that could lead to sudden cardiac arrest. In 2021 the company partnered with Dreamtech, reinforcing its position as a leading innovator in cardiac diagnostics, and in 2023 it launched Heart@Home ECG Test Kit to meet telehealth demands.